USD 1.07 billion
Influenza Diagnostics Market Size, Share, Growth Analysis, By Test Type(Traditional Diagnostic Test, Molecular Diagnostic Assay), By End-User(Hospital, Laboratories, Other End Users), By Region - Industry Forecast 2024-2031
Report ID:
SQSG35G2011 |
Region:
Global |
Published Date: February, 2024
Pages:
165
|Tables:
62
|Figures:
75
Influenza Diagnostics Market Insights
Influenza Diagnostics Market size was valued at USD 1.07 billion in 2019 and is poised to grow from USD 1.1 billion in 2023 to USD 1.46 billion by 2031, growing at a CAGR of 3.5% in the forecast period (2024-2031).
Increasing healthcare expenditure and the availability of effective treatment options have led to an increase in the median age worldwide. The WHO, CDC, and European Centre for Disease Prevention and Control, among other regulatory bodies, are actively recording incidence & prevalence data to counter the disease systematically. These bodies work together with local governments to achieve overall control of the treatment and management of this disease. The Global Influenza Program (GIP) is one initiative the WHO undertook to provide technical support, strategic guidance, and coordination activities concerning zoonotic, pandemic, and seasonal flu cases. Such initiatives are expected to boost market growth during the forecast period. COVID- 19 has had a significant impact on the influenza diagnostics market across the globe. Many manufacturing facilities have ceased or closed because of the nation-wide lockdowns. Unfavorable regulations and guidelines changes of many disease diagnostics are hampering the flu diagnostic medium market. Supply chain disruptions in and responses to the spread of COVID- 19 are expected to have an impact. Besides, COVID- 19 and influenza have multiple things in common – Both of them are contagious viruses and also show similar symptoms of respiratory illness. Hence, it is mandatory to test for influenza, whenever COVID-19 affects the respiratory system of a patient. This is creating an increasing testing for influenza.
US Influenza Diagnostics Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Traditional Diagnostic Test
Fastest Growth
Traditional Diagnostic Test
Growth Rate
3.5% CAGR
Global Influenza Diagnistics Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Influenza Diagnostics Market Segmental Analysis
The Global Influenza Diagnostics Market is segmented based on Test Type, End-User, and Region. Based on Test Type it is categorized into Traditional Diagnostic Test and Molecular Diagnostic Assay. The Traditional Diagnostic Test segment is further bifurcated into RIDT, Viral Culture, Direct Fluorescent Antibody (DFA) Test, and Serological Assay. Molecular Diagnostic Assay is sub-segmented into RT-PCR, Nucleic Acid Sequence-based Amplification (NASBA) Test, Loop-mediated Isothermal Amplification-based Assay (LAMP), Simple Amplification-based Assay (SAMBA), and Other Molecular Diagnostic Assays. By End User, the Influenza Diagnostics Market studied is segmented into hospitals, Laboratories, and Other End Users. Based on the region it is categorized into North America, Europe, Asia-Pacific, South America, and MEA.
Influenza Diagnostics Market Analysis by Test Type
Based on test type, the traditional diagnostics test segment is dominating the Influenza Diagnostics market with the largest revenue. The development and growth of traditional diagnostic tests is determined by factors such as their availability, cost, and the speed with which they provide results. Previous technologies, such as molecular methods and point-of-care nucleic acid amplification tests, are still in high demand today, but traditional tests continue to hold a special place. For starters, traditional tests can be highly effective in both healthcare and other settings, particularly when the number of people who need to be tested is higher and they need to get the results quickly. In addition, they can be of more use in remote hospitals and rural areas where sophisticated molecular tests are not available. Finally, conventional tests typically have a lower cost and are more accessible to people with a low-income level.
The rapid diagnostic test segment is estimated to witness the fastest growth in the market. Growing preference of the physicians for RIDT over other test types that include molecular tests, RT-PCR tests, viral culture, and serology factors contribute to segment growth. The growing awareness of the general population about the influenza infectious disease and advancements in testing technologies are expected to derive the sub-segment growth. Rapid influenza diagnostic tests, which are otherwise called Point-of-Care Tests, provide a quick method for detection of particular viral influenza antigens in the samples of the patient that are collected for the respiratory diseases. These tests are widely available commercially on cassettes, cards, and dipsticks.
Influenza Diagnostics Market Analysis by End-user
Based on end-user, the hospital segment is dominating the Influenza Diagnostics market with maximum market share. This is evident by increasing hospitalization of influenza patients. Hospitals are the first point of care for diagnosis and treatment. A large part of the population relies on these long-term facilities for diagnosis, treatment, and disease management. The nature of changes in the health care industry constantly demands hospitals with advanced facilities. Healthcare is constantly growing worldwide in terms of expenditure, hence contributing to market growth. Besides, hospitals collect and keep records of the occurrence of diseases thus regulatory bodies frequently combine the data to analyze disease surveillance.
Point of Care Testing is expected to be the fastest-growing market for Influenza Diagnostic Testing. Most of the Influenza Diagnostic Testing are classified as CLIA waived that are typically used in point of care settings. Being easy to handle, high specificity & sensitivity, rapid turnaround times, and better results are the major market drivers for this segment. Moreover, technological advancements in POC test kits which could provide error-free results in less turnaround times are expected to boost the market in the near future. Hence, due to the increasing incidence of this disease, this segment is expected to fuel market growth over the forecast period.
To get detailed analysis on other segments, Request For Free Sample Report
Influenza Diagnostics Market Regional Insights
North America is dominating the Influenza Diagnostics market with the largest market share. The North American region dominated the diagnostic market in 2023 which was mainly due to the government’s support for high-quality healthcare, increase in focus of influenza outbreak, and the high buying power. The U.S. was the largest revenue contributor to the North American market in 2023. This is mainly because the U.S. market is expected to grow due to the well-established healthcare infrastructure and increase in programs for influenza diagnostics. These factors are increasing the growth of the influenza diagnostics market in the North America region.
The Asia Pacific is poised for substantial growth during the forecast period. This is due to the fact that in countries such as India and China, where there is increasing awareness of diseases and an increasing incidence of cancer & diabetes, there are also growth opportunities. Influenza is a major concern for the Chinese population and is the most lethal type of disease. Jiangsu, Zhejiang, Hunan, Shanghai, Guangdong, and Fujian provinces in China were most severely affected during the pandemic. The demand for diagnostic products is anticipated to rise as improving the country’s disease containment efforts, such as enhanced surveillance and cancelling live poultry markets, take precedence.
Global Influenza Diagnostics Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Influenza Diagnostics Market Dynamics
Influenza Diagnostics Market Driver
Growing Focus on Influenza Diagnostic Research
- The rising global prevalence of influenza has surged the R&D activities for the accurate detection and diagnosis. Although the major concentration of research activities is targeted towards the development of a rapid and precise diagnosis of the influenza viruses, it will drive market growth as well. In addition to this, the rising incidences of government initiatives against the outbreak of influenza, technological advancements, and the increasing incidences of cardiovascular diseases and diabetes will provide a further push to market growth.
Development in Genomic Technologies
- Many assays and technologies have been developed to diagnose and manage influenza infection because of the human genome project and the advances made in molecular and biomedical technologies. These technologies, which are mainly genomic such as PCR, and proteomics, such as microarray detection, are useful in the discovery of new types of influenza virus. In addition, they may help in surveillance and rapid diagnosis of an infectious disease, which is a market opportunity.
Restraints
Lack of Skilled Technicians
- The lack of skilled and professional personal along with unstable regulatory framework of new diagnostic test approval will obstruct the market’s growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the market.
Complexity of Influenza Virus
- Influenza diagnostic tests are generally influenced by sensitivity and specificity which are a consequence of the antigenic variation by influenza viruses. Due to this factor, influenza diagnostic tests have varied sensitivity and specificity. Periods of high prevalence and circulation of influenza are associated with high levels of false-negative results which are more common than false-positive results, a factor that hinders the growth of the influenza diagnostics market.
Request Free Customization of this report to help us to meet your business objectives.
Influenza Diagnostics Market Competitive Landscape
The Influenza Diagnostics market is undergoing greater regulatory scrutiny. Presently, companies spend considerable resources on clinical trials and submissions to meet regulatory requirements for diagnosing new tests. This may impose substantial pressure on the cost of developing novel influenza diagnostics technologies. Therefore, governments across the globe are developing regulations to manage the development and control the cost of testing. These regulations can significantly impact the things for the market and products will be affected for the development and adoption perspective.
Influenza Diagnostics Market Top Player’s Company Profiles
- Thermo Fisher Scientific, Inc.
- Roche Diagnostics
- Abbott Laboratories
- Becton, Dickinson and Company
- Quidel Corporation
- DiaSorin S.p.A.
- bioMérieux SA
- Meridian Bioscience, Inc.
- Luminex Corporation
- Hologic, Inc.
- F. Hoffmann-La Roche Ltd.
- Cepheid Inc.
- Sekisui Diagnostics LLC
- GenMark Diagnostics, Inc.
- Quanterix Corporation
- Alere Inc.
- Merck KGaA
- Hologic, Inc.
- Scienion AG
- Enzo Biochem, Inc.
Influenza Diagnostics Market Recent Developments
- Becton, Dickinson and Company got the U.S. FDA clearance for a respiratory viral panel in August 2023 for the identification of patients infected by flue and respiratory syncytial virus.
- Lucira COVID-19 & Flu Home Test, developed by Pfizer Inc. was cleared in February 2023 by the U.S. FDA emergency use of authorization approval to diagnose influenza viruses A and B. The test is an over the counter at-home diagnostic test.
- In October 2022, the European and North American regulatory bodies provided Hologic Inc. approval ti launch its Aptima SARS-CoV-2/Flue test.
Influenza Diagnostics Key Market Trends
- Increasing in the Reported Cases of Influenza: The global influenza diagnostics market is expected to experience growth due to the increased occurrence of influenza. According to the centers for disease control and prevention on average about 12,000- 79,000 people die of Influenza each year in the United States. The market is also expected to grow during the forecast period because of the increasing awareness of the importance of early detection and prevention of diseases such as influenza.
- Increasing Number of Vaccinations: Vaccination is one of the predominant ways to immunize people against infectious diseases for avoiding severe complications, especially in immunocompromised people who are more venerable to infection. However, the mutation in the virus serotype is a significant hindrance on the grounds of it becoming challenging to vaccinate an individual in such a case. Due to the mutations in types of viruses, it is vital to perform the identification of pathogens among patients and provide them with required medication on time to prevent mortality. Thus, the influenza diagnostics products market is experiencing a rise in demand and the market growth has been escalated.
Influenza Diagnostics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global market of Influenza diagnostics is highly innovative; new diagnostic technologies and methods, the most popular of which is Reverse Transcriptase-Polymerase Chain Reaction, are being developed and introduced regularly. It has turned into a common choice as a diagnostic method, and therefore market players invest in innovative technologies and procedures to meet the demand. The influenza diagnostics market is mainly driven by an increased risk of flu among geriatric population, rise in the healthcare expenditure and the availability of effective treatment options over the forecast period.
| Report Metric | Details |
|---|---|
| Market size value in 2019 | USD 1.07 billion |
| Market size value in 2031 | USD 1.46 billion |
| Growth Rate | 3.5% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Influenza Diagnostics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Influenza Diagnostics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Influenza Diagnostics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Influenza Diagnostics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Influenza Diagnostics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Influenza Diagnostics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
